Home/Nymox Pharmaceutical/Robert J. Molinari
RJ

Robert J. Molinari

Former Chief Operating Officer

Nymox Pharmaceutical

Therapeutic Areas

Nymox Pharmaceutical Pipeline

DrugIndicationPhase
Fexapotide Triflutate (NX-1207)Benign Prostatic Hyperplasia (BPH)Phase 3